COVID-19 Vaccine (inactivated, adjuvanted) Valneva Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - Εμβόλια - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Spikevax (previously COVID-19 Vaccine Moderna) Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Jcovden (previously COVID-19 Vaccine Janssen) Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - Εμβόλια - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - Εμβόλια - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

PHYSIONEAL 40 GLUCOSE SOL.PER.DI 3,86% W/V 38,6MG/ML (CLEAR FLEX) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

physioneal 40 glucose sol.per.di 3,86% w/v 38,6mg/ml (clear flex)

baxter hellas ΕΠΕ Μαρίνου Αντύπα 47 & Ανάφης, 141 21 Ν. Ηράκλειο 210.2880000 - dextrose(glucose) monohydrate; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; sodium (s) lactate solution; dextrose(glucose) monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium bicarbonate; sodium (s) lactate solution - sol.per.di (ΔΙΑΛΥΜΑ ΠΕΡΙΤΟΝΑΙΚΗΣ ΔΙΑΠΙΔΥΣΗΣ (ΚΑΘΑΡΣΗΣ)) - 3,86% w/v 38,6mg/ml (clear flex) - dextrose(glucose) monohydrate 20g; calcium chloride dihydrate 0,25g; magnesium chloride hexahydrate 0,07g; sodium chloride 19,95g; sodium bicarbonate 9,29g; sodium (s) lactate solution 6,73g; dextrose(glucose) monohydrate 15g; sodium chloride 5,38g; calcium chloride dihydrate 0,18g; magnesium chloride hexahydrate 0,05g; sodium bicarbonate 2,1g; sodium (s) lactate solution 1,68g - hypertonic solutions - hypertonic solutions

ΔΕΞΤΡΟΖΗ/ΒΙΟΣΕΡ INJ.SOL 38,5 (35) % W/V Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

δεξτροζη/βιοσερ inj.sol 38,5 (35) % w/v

ΒΙΟΣΕΡ Α.Ε. ΒΙΟΜΗΧΑΝΙΑ ΠΑΡΕΝΤΕΡΙΚΩΝ ΔΙΑΛΥΜΑΤΩΝ Δ.Τ. ΒΙΟΣΕΡ Α.Ε. 9ο χλμ. Εθνικής Οδού Τρικάλων-Λάρισας, 421 00 Ταξιάρχες, Τρίκαλα 2431 083441-2 - dextrose(glucose) monohydrate - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 38,5 (35) % w/v - dextrose(glucose) monohydrate 38,5g - carbohydrates

ΔΕΞΤΡΟΖΗ/ΒΙΟΣΕΡ INJ.SO.INF 38,5 (35) % W/V Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

δεξτροζη/βιοσερ inj.so.inf 38,5 (35) % w/v

ΒΙΟΣΕΡ Α.Ε. ΒΙΟΜΗΧΑΝΙΑ ΠΑΡΕΝΤΕΡΙΚΩΝ ΔΙΑΛΥΜΑΤΩΝ Δ.Τ. ΒΙΟΣΕΡ Α.Ε. 9ο χλμ. Εθνικής Οδού Τρικάλων-Λάρισας, 421 00 Ταξιάρχες, Τρίκαλα 2431 083441-2 - dextrose(glucose) monohydrate - inj.so.inf (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ) - 38,5 (35) % w/v - dextrose(glucose) monohydrate 38,5g - carbohydrates

PHYSIONEAL 35 GLUCOSE SOL.PER.DI 3,86% W/V 38.6MG/ML (CLEAR FLEX) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

physioneal 35 glucose sol.per.di 3,86% w/v 38.6mg/ml (clear flex)

baxter hellas ΕΠΕ Μαρίνου Αντύπα 47 & Ανάφης, 141 21 Ν. Ηράκλειο 210.2880000 - dextrose(glucose) monohydrate; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; sodium (s) lactate solution; dextrose(glucose) monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium bicarbonate; sodium (s) lactate solution - sol.per.di (ΔΙΑΛΥΜΑ ΠΕΡΙΤΟΝΑΙΚΗΣ ΔΙΑΠΙΔΥΣΗΣ (ΚΑΘΑΡΣΗΣ)) - 3,86% w/v 38.6mg/ml (clear flex) - dextrose(glucose) monohydrate 56,6g; calcium chloride dihydrate 0,34g; magnesium chloride hexahydrate 0,07g; sodium chloride 21,12g; sodium bicarbonate 9,29g; sodium (s) lactate solution 4,48g; dextrose(glucose) monohydrate 42,5g; sodium chloride 5,67g; calcium chloride dihydrate 0,26g; magnesium chloride hexahydrate 0,05g; sodium bicarbonate 2,1g; sodium (s) lactate solution 1,12g - hypertonic solutions - hypertonic solutions

PHYSIONEAL 35 GLUCOSE SOL.PER.DI 3,86% W/V(38,6MG/ML) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

physioneal 35 glucose sol.per.di 3,86% w/v(38,6mg/ml)

baxter hellas ΕΠΕ Μαρίνου Αντύπα 47 & Ανάφης, 141 21 Ν. Ηράκλειο 210.2880000 - dextrose(glucose) monohydrate; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium bicarbonate; sodium (s) lactate solution; dextrose(glucose) monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium (s) lactate solution; sodium bicarbonate - sol.per.di (ΔΙΑΛΥΜΑ ΠΕΡΙΤΟΝΑΙΚΗΣ ΔΙΑΠΙΔΥΣΗΣ (ΚΑΘΑΡΣΗΣ)) - 3,86% w/v(38,6mg/ml) - dextrose(glucose) monohydrate 117,14g; calcium chloride dihydrate 0,71g; magnesium chloride hexahydrate 0,14g; sodium chloride 8,89g; sodium bicarbonate 3,29g; sodium (s) lactate solution 1,76g; dextrose(glucose) monohydrate 42,5g; sodium chloride 5,67g; calcium chloride dihydrate 0,257g; magnesium chloride hexahydrate 0,051g; sodium (s) lactate solution 1,12g; sodium bicarbonate 2,1g - hypertonic solutions - hypertonic solutions

SCHERIPROCT NEO OINT.REC.A (0,19+0,5)% Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

scheriproct neo oint.rec.a (0,19+0,5)%

karo pharma aktiebolag, sweden box 16184, 103 24 stockholm +46 10-330 23 10 - prednisolone caproate; cinchocaine hydrochloride - oint.rec.a (ΟΡΘΙΚΗ ΑΛΟΙΦΗ) - (0,19+0,5)% - prednisolone caproate 1,9mg; cinchocaine hydrochloride 5mg - prednisolone